389 related articles for article (PubMed ID: 7181563)
21. Rural Kenya: measles during pregnancy and early infancy.
Arya SC; Agarwal N
J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
[No Abstract] [Full Text] [Related]
22. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
23. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
[TBL] [Abstract][Full Text] [Related]
24. [Anti-measles humoral immunity in children with thymus hyperplasia].
Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
[TBL] [Abstract][Full Text] [Related]
25. [Post-vaccination measles immunity in children on long-term anticonvulsant therapy].
Popović-Miocinović L; Smerdel S; Grubesić Z; Miklousić A
Lijec Vjesn; 1994; 116(3-4):74-8. PubMed ID: 8057741
[TBL] [Abstract][Full Text] [Related]
26. Low seroconversion rates to measles vaccine among children in Nigeria.
Adu FD; Akinwolere OA; Tomori O; Uche LN
Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
[TBL] [Abstract][Full Text] [Related]
27. Ineffectiveness of historical data in predicting measles susceptibility.
Scott RM; Butler AB; Schydlower M; Rawlings P
Pediatrics; 1984 Jun; 73(6):777-80. PubMed ID: 6728580
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of measles vaccination in young malnourished African children].
Monjour L; Bourdillon F; Froment A; Claudio-Ribeiro D; Fabre M; Chastang C; Gentilini M
Bull Soc Pathol Exot Filiales; 1984; 77(3):271-7. PubMed ID: 6488419
[TBL] [Abstract][Full Text] [Related]
29. Serological survey of measles in Yemen in 1985.
Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
[TBL] [Abstract][Full Text] [Related]
30. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
31. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
32. Modifications of IFN-alpha, TNF-alpha and IFN-gamma serum levels in children vaccinated against measles.
Liguori G; Tolone C; D'Avanzo M; Corbisiero G; Di Benedetto R; Del Prete U
Ann Ig; 1998; 10(5-6):303-6. PubMed ID: 10052194
[No Abstract] [Full Text] [Related]
33. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
[No Abstract] [Full Text] [Related]
34. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
[No Abstract] [Full Text] [Related]
35. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
36. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
Biberi-Moroeanu S; Munţiu A; Tiţeica M
Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
[No Abstract] [Full Text] [Related]
37. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
Willis MF; Warburton MF
Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
[No Abstract] [Full Text] [Related]
38. [The transmission of maternal measles antibodies to newborn infants in the Ivory Coast].
Rey JL; Lhuillier M; Dem M; Soro B; Saki Z; Davis CE
Med Trop (Mars); 1991; 51(2):215-8. PubMed ID: 1654494
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of UV-inactivated measles virus.
Zahorska R; Mazur N; Korbecki M
Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):424-30. PubMed ID: 696055
[TBL] [Abstract][Full Text] [Related]
40. [Status of immunization against measles in the pediatric population of the province of Ferrara].
Bezzi TM; Soriani S; Trombini R; Scorrano M
Minerva Pediatr; 1980 Apr; 32(8):581. PubMed ID: 7393191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
